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Addiction coopts the brain’s neuronal circuits necessary for insight, reward, motivation, and social behav-
iors. This functional overlap results in addicted individuals making poor choices despite awareness of the
negative consequences; it explains why previously rewarding life situations and the threat of judicial punish-
ment cannot stop drug taking andwhy amedical rather than a criminal approach ismore effective in curtailing
addiction.Introduction
Substanceusedisorders (SUD)profoundly
affect our society. Though the costs are
usually translated in economic terms—
approximately half a trillion dollars a year
in the USA (ONDCP, 2004)—their impact
is much more insidious, eroding the
foundation of human relationships and
the established social contract. Thus, it is
not surprising that a significant portion of
costs associated with SUD stems from
costs associatedwith antisocial or criminal
behavior and family services. The following
letter excerpt (bold added for emphasis)
painfully illustrates the devastation
that SUD can bring upon individuals, their
families, and society.
As I sit to compose this plea I can’t
say with any amount of certainty
that my son is alive. My son discov-
ered narcotics at the age of 13. He
experienced a severe orthopedic
sports injury. There seems to be
nothing that can induce him to
stop for any appreciable length
of time. I had him arrested May
of 2006 for heroin possession
and identity fraud, he stole
900 dollars from our checking
account while I was in Connecti-
cut burying my dad and his sister
. tells me he cannot stop.. Our
family is being destroyed . we
have exhausted our savings and
retirement. Everything seems so
hopeless.
Research on the neuroscience of SUD
has started to shed light on the ways inwhich chronic drug abuse changes the
brain to cause the profound disruption
we see in the behavior of an addicted
person. This is because drugs of abuse
impact many neuronal circuits that are
crucial for proper functioning in social
environments. These changes are long-
lasting, persisting even after years of
drug discontinuation, which has led to
the recognition of addiction as a chronic
and relapsing disease, as illustrated by
another letter excerpt.
I am a 42 year old male who has
struggled with addiction to alcohol/
drugs for almost two decades but I
have also struggled with trying to
find a way out of active addiction.
My attempts have included about
15 stays at rehabilitation centers,
numerous detoxification units, a
stay at a long-term rehabilitation
center, religion, philosophy, be-
havior modification and finally a 12
step program.. My life can be
summed-up as a life of many
failed attempts. Failed attempts in
a lot of areas and I believe it is
because I have not been able to
stop abusing alcohol.
Addiction has a strong genetic compo-
nent and both developmental stages
(adolescents and young adults being at
the highest risk for SUD) and environ-
mental factors (e.g., exposure to stressful
environments) play crucial roles in modu-
lating the vulnerability for SUD in part
through their influence on how the human
brain works and responds and adapts toNeuron 69,various types of stimuli (including drugs).
Scientific insights into drug-induced
impairments of specific brain circuits are
beginning to answer many of the ques-
tions that had baffled us for so long,
such as (1) why drugs can be so disruptive
to social relationships, (2) why the social
system used to deter behavior (e.g., the
threats of incarceration or of loss of
custody) does not work well in addicted
subjects, (3) why social stressors (such
as those that may be triggered by poverty)
increase vulnerability for addictions, and
(4) how to best harness the new informa-
tion for the development of more effective
prevention and treatment alternatives.
Fundamental processes to addiction are
the enhanced motivational drive for the
drug and the weakening of control over
this drive.
What’s Important to Addicts:
Placing Value in All the Wrong
Places
People’s ability to successfully identify,
seek, and obtain what is important to
them (but also avoid what’s undesirable)
at a particular point in time is crucial for
their well-being. That which motivates us
toward obtaining certain goals plays
a key role in how successfully we navigate
complex social environments. The sinister
nature of addiction is that the very neuro-
biological systems underpinning this
process become dysfunctional, hijacked
by a user’s drug (or drugs) of choice.
From a biological perspective, this is
believed to reflect the ability of chronic
drug exposure to cause neuroadaptations
in brain reward systems including theFebruary 24, 2011 ª2011 Elsevier Inc. 599
Figure 1. Model Proposing a Network of Four Circuits Involved with Addiction: Reward,
Motivation/Drive, Memory, and Control
These circuits work together and change with experience. Each is linked to an important concept: reward
(value of positive and negative reinforcers), drive (incentive motivation), memory (learned associations/
conditioning), and control (conflict resolution). During addiction, the enhanced value of the drug in the
reward, motivation, and memory circuits overcomes the inhibitory control exerted by the prefrontal
cortex, thereby favoring a positive-feedback loop initiated by the consumption of the drug and perpetu-
ated by the enhanced activation of the motivation/drive and memory circuits (reprinted with permission
[Volkow et al., 2003]).
Neuron
NeuroViewemergence of conditioned associations
that link the rewarding experience from
the drug to the multiple cues that sur-
round it (Kalivas and Volkow, 2005).
The same functional impairments that
make the reward pathways of an addicted
individual more responsive to the abused
drug and its associated cues (Volkow
et al., 2009) also reduce their sensitivity
to previously effective natural nondrug
reinforcers, such as spending time with
friends or family. The intrinsically high
rewarding properties of drugs of abuse
combined with their relatively weak
potential for satiety (Acquas and Di
Chiara, 1992) trigger neuroadaptations
that ultimately make drug searching and
consumption the main motivational drive
for addicted individuals. As a result, in ad-
dicted subjects, the reward value of the
drug of abuse and its associated cues is
enhanced, whereas that of other rein-
forcers is markedly decreased (Volkow
et al., 2003) (Figure 1). Ultimately, this
leads to a cycle of drug abuse that is
difficult to break free of, even when an
addict may truly want to become drug-
free, resulting in the typical pattern of
drug relapse so often seen in addicted
individuals.600 Neuron 69, February 24, 2011 ª2011 ElsFurthermore, while the value that an
addicted individual places on drug reward
becomes unsustainably exaggerated, the
potential impact of deleterious con-
sequences (e.g., familial dislocation,
becoming the target of drug-related
violence, or incarceration) becomes pro-
gressively devalued. The establishment
of such a severe imbalance in how an
addicted individual attributes value to
both rewarding and aversive situations
and stimuli has a profound and negative
impact on the individual’s social compe-
tence. Their behaviors are now governed
by the uncontrollable overvaluing of the
drug and by a growing insensitivity to
the deterrent value of potential punish-
ments. The problem is further com-
pounded by the tendency of many sub-
stance abusers, more so than nonusers,
to routinely choose immediate rewards
over delayed gratification (e.g., choose
$20 dollars now rather than wait 1 week
in order to get double that amount). This
inability to appropriately weigh delayed
rewards can be devastating to an ad-
dicted person whomay bewilling to sacri-
fice future gains or incur major losses
in exchange for instant gratification. An
individual in this situation may not thinkevier Inc.twice about the risk of losing his or her
parole tomorrow in order to chase the
high from the drug now.
This knowledge helps explain why
the prevailing social system that dangles
some future threat of imprisonment
over an addict’s head does not work
well in deterring immediate substance
abuse-related behaviors in addicted
subjects. It also highlights the need to
provide addicted individuals with alter-
native reinforcers as a strategy both for
the prevention of SUD as well as its
treatment.
When Both Steering and Braking
Systems Fail: Cognitive Function
and Impulse Control Derailed
For many years, studies of addiction
focused on the role of brain reward
circuitry (Weiss and Koob, 2001).
However, imaging studies have provided
consistent evidence for the involvement
of the brain’s cognitive system as well
(i.e., prefrontal cortex [PFC]) in the addic-
tion process (Volkow and Fowler, 2000).
Both preclinical and clinical studies have
explored the complex role that disrupted
cognitive processing plays in the addic-
tion cycle. In addition to the involvement
of the PFC in classical cognitive opera-
tions, more recent work has also revealed
that the PFC plays a crucial role in social
cognition (Forbes and Grafman, 2010),
which is necessary for proper social inte-
gration. For example, damage to ventral
areas of this brain region can interfere
with the ability of a person to accurately
distinguish right from wrong in a socially
acceptable manner, which can lead to
socially inappropriate behaviors (Koenigs
et al., 2007). Because the functions of
these brain regions are also impaired in
addicted individuals, this could explain
an addict’s inability to accurately steer
their behaviors in appropriate directions
despite having access to the required
knowledge.
Behavioral inhibition is fundamental to
the success of social intercourse, which
is critically dependent on a person’s
ability to control impulsive behaviors
whenever this is needed. It is therefore
interesting to note that impaired impulse
behavior, which is also dependent on the
PFC, is another key symptom of addictive
individuals. For most people, the combi-
nation of biological (e.g., individual-level
Neuron
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culture, laws, religion) factors build up a
sufficiently robust mechanism to inhibit
or at least help manage internally or exter-
nally generated temptations. But the
system is not fail-safe and some individ-
uals at one extreme of the impulsivity
distribution curve, as is the case in addic-
tion, are the constant victims of very
powerful, unstoppable urges. By perturb-
ing the function of the PFC, the addiction
process degrades the very substrates
that enable an individual to exert free
will. There is no doubt that the impaired
function of neuronal systems involved in
social behaviors in addicted individuals
contributes to the stigma associated
with SUD.
Social Stressors and Addiction
Lingering economic uncertainty, social
dislocation, isolation, inequalities, and
the ubiquitous threat of global terrorism
are just a few examples of modern life’s
steady diet of stressful stimuli that could
exacerbate the risk of mental illness
including SUD. Stress systems greatly
contribute to the addiction cycle of drug
craving and withdrawal, pushing the
addicted individual toward compulsive
drug taking (Koob and Zorrilla, 2010).
Indeed, epidemiological studies have
shown a direct dose-dependent relation-
ship between the number and type of
adverse childhood experiences (ACE)
and early initiation of drug use (Dube
et al., 2003). Such ACEs appear to explain
at least half of the risk for SUD later in life.
Of particular interest for neuroscience
research has been the role of social
stressors in SUD. For example, in non-
human primates stressful alterations in
an animal’s social environment disrupted
their expression of dopamine D2 recep-
tors (D2R) in striatum and increased their
subsequent propensity for drug use
(Morgan et al., 2002). Similarly, imaging
studies in humans have documented an
inverse relationship between social status
and striatal D2R expression (Martinez
et al., 2010). This is relevant because
both preclinical and clinical studies have
shown that low striatal D2R expression
is associated with impulsivity and propen-
sity for compulsive drug use. Indeed, one
of the most replicated findings from
imaging studies of addiction is that of
reduced striatal D2R levels (Volkowet al., 2009). Hence, one possible mecha-
nism throughwhich social stressorsmight
enhance the risk for drug use could
involve the downregulation of striatal
dopamine signaling.
Social stressors have also been shown
to have a deleterious impact on the devel-
opmental processes that connect the
PFC with the limbic brain (including the
amygdala, which processes emotions
and stress reactivity) and that are indis-
pensable for the establishment of cogni-
tive control of emotions and desires. For
example, children reared in an orphanage
showed a delayed connectivity in these
pathways that was proportional to the
years they spent at that institution (Behen
et al., 2009).
The fact that stressful stimuli and envi-
ronments can exert such negative and
long-lasting effects on the formation and
function of the brain substrates respon-
sible for protecting us against drug abuse
and addiction (among others) should
make us pause and rethink our prevention
strategies. For example, should we con-
sider how the enhanced stress of having
an incarcerated parent may affect the
risk for drug use in the children of incar-
cerated drug abusers or consider the
neurobiological consequences of incar-
ceration in the drug abuser and how this
will affect their ability to recover once
released into their communities?
Implications for Treatment
and Social Policy
As we’ve discussed above, addiction
involves persistent drug-induced adapta-
tions in the brain systems responsible for
controlling behaviors that are necessary
for proper integration into complex social
systems. Hence, therapeutic interven-
tions should take this into consideration
and create incentives for the substance
abusers to engage and stay in treatment
including strategies that help strengthen
social ties with family and community.
Social interactions are powerful rein-
forcers that can provide the addicted indi-
vidual with alternatives to help counteract
the perceived high-reward value of drugs.
An important consequence of the long-
term brain adaptations is that most ad-
dicted patients will require a long period
of treatment, during which relapse is likely
to occur, which should be considered a
predictable setback and not a failure ofNeuron 69,the treatment. This also explains why the
best treatment outcomes are reported
by programs that offer continuity of care
for a 5-year period (McLellan et al.,
2008). In addition, chronic drug abuse
has recently been recognized to be asso-
ciated with impaired self-awareness
(including interoceptive or bodily aware-
ness), which manifests as compromised
recognition of disease severity and/or
the need for treatment, but that has
frequently been interpreted as denial
(Goldstein et al., 2009). This in turn
contributes to the low rates of treatment
initiation and high-dropout rates.
According to the 2010 National Survey
on Drug Use and Health (NSDUH)
(SAMHSA, 2010), in 2009, 22.5 million
persons aged 12 or older needed treat-
ment for an illicit drug or alcohol use prob-
lem, but only 2.6 million received treat-
ment at a specialty facility. This means
that 20.9 million persons who needed
treatment did not get it. The reason for
such high undertreatment rates is instruc-
tive: the vast majority of addicts did not
even perceive a need for treatment and
among those who did admit needing
treatment over half either didn’t make
any effort to seek it or were unable to
procure it. The persistence of such a
vast SUD treatment gap—the result of a
combination of inadequate infrastructure
and lack of interest—is a great concern
because it continues in spite of the avail-
ability of effective interventions.
The disconnect that exists between
treatment needs and access is even
more apparent in the context of criminal
justice system populations. The fact is
that most prisoners (80%–85%) who
could benefit from drug abuse treatment
do not receive it (Mumola and Karberg,
2006). This is a missed opportunity
because integrating treatment into the
criminal justice system would enable us
to provide treatment to individuals who
otherwise would neither seek nor receive
it, and it has been shown to improve
medical outcomes and reduce recidivism
particularly when maintained throughout
the critical postrelease period (Chandler
et al., 2009). This is because returning to
a neighborhood awash with so many
drug-associated cues can trigger power-
ful cravings and relapse to compulsive
drug-seeking behaviors. This is further
compounded by the systemic difficultiesFebruary 24, 2011 ª2011 Elsevier Inc. 601
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reintegrating into society, including that of
finding a job while under the shadow of
a criminal record. This is vividly illustrated
by the following letter.
I amwriting as themother of a crack
addict. My daughter has been an
addict for 12 years. She is the
mother of 4 children all of which
she has lost parental rights to. She
has been in prison most of the 12
years, and had many programs,
doing well in what was offered
during incarceration. When she is
released from prison, she is always
hopeful for success. She is
immediately faced with 4 major
challenges: getting a place to live,
finding a job, transportation, and
obtaining continuing recovery
treatment.. Now she just got
[out] of jail 3 weeks ago, went
through what I just described
above, and went back on the
streets. She was broke and shop-
lifting, and now will go back to jail,
do the program for probably the
10th time, and be released again
the same way. There are many like
my daughter, so addicted they will
end up dead.Forward-Looking Agenda
I wonder how many times my son
has left in him. Is there any hope
for the alcoholic/addict who has
reached bottoms so deep and so
dark that it is hard to imagine
that there is any place left to go?
That there is anything left to lose.
When there are no more resources,
no money, no free treatment
options that are available during
the unending crisis—what then?
When a bright, educated man can
no longer work because of his602 Neuron 69, February 24, 2011 ª2011 Elsaddiction, where do we turn? I ask
because I have done everything
and I have done nothing and neither
strategy has worked.
Social isolation is not only a marker but
a well-recognized risk factor of physical
and mental illness (Karelina and DeVries,
2011). Yet, by most accounts, stigmatiza-
tion and/or incarceration have been soci-
ety’s prevailing responses to addicted
individuals. Such stigmatization impedes
the search for treatment and further
isolates addicted individuals and their
families.
The ideas expressed here could be
easily construed as advocating a sort of
moral relativism at the expense of indi-
vidual responsibility. Yet nothing could
be farther from the truth. We merely state
the fact that addiction is a brain disorder
that impacts the very same circuits that
enable self-monitoring and complex
social functioning. Granted, our under-
standing of the brain systems whose
function or dysfunction shape subjective
value and decision-making and how
drugs affect them is still incomplete.
Nonetheless, the recognition that social
stressors such as stigma and isolation
can further impair the function of neuronal
systems necessary for an addicted
person’s recovery highlights the need to
treat addiction as a disease rather than
as a criminal behavior.ACKNOWLEDGMENTS
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